" class="no-js "lang="en-US"> Hummingbird Bioscience Archives - Pharmtech Focus
Friday, January 27, 2023

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]

Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, […]

Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, […]

Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration to Advance Innovative Immunotherapies

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]

  1. Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors Read more
  2. Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication Read more
  3. New AI Tool Makes Speedy Gene Editing Possible Read more
  4. European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease Read more
  5. Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Read more